Premphase 14/14 Interactions
There are 299 drugs known to interact with Premphase 14/14 (conjugated estrogens / medroxyprogesterone), along with 25 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 40 are major, 238 are moderate, and 21 are minor.
- View all 299 medications that may interact with Premphase 14/14
- View Premphase 14/14 alcohol/food interactions (6)
- View Premphase 14/14 disease interactions (25)
Most frequently checked interactions
View interaction reports for Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) and the medicines listed below.
- alprazolam
- cetirizine
- dextromethorphan / guaifenesin
- diclofenac
- hydrocodone / ibuprofen
- levothyroxine
- methimazole
- omeprazole
- pseudoephedrine
- venlafaxine
- Wellbutrin XL (bupropion)
Premphase 14/14 alcohol/food interactions
There are 6 alcohol/food interactions with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone).
Premphase 14/14 disease interactions
There are 25 disease interactions with Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone) which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- bone mineral density
- menstrual bleeding
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.